In our previous prospective study involving 209 patients treated with anti-programmed cell death-1 (PD-1) antibodies, only one case (0.5%) was diagnosed with hyperthyroidism, based on thyroid scintigraphy (14). This evidence concerns the gene PDCD1 and hyperthyroidism.